Drugs / CNU
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03844100 | Nov 2019 → Aug 2021 | bile duct disorder, dyspepsia | Gangnam Severance Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03844100 ↗ |
| Route | Oral | “CNU capsule orally” NCT03844100 ↗ |